학술논문

Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review.
Document Type
Article
Source
Clinical & Experimental Dental Research; Apr2024, Vol. 10 Issue 2, p1-16, 16p
Subject
BOTULINUM A toxins
TRIGEMINAL neuralgia
NEURALGIA
CARBAMAZEPINE
TERMINATION of treatment
Language
ISSN
20574347
Abstract
Copyright of Clinical & Experimental Dental Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)